IL128535A - Process for r-epimer enrichment of 16, 17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11 beta, 16 alpha, 17 alpha-triol-3,20-dione derivatives - Google Patents

Process for r-epimer enrichment of 16, 17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11 beta, 16 alpha, 17 alpha-triol-3,20-dione derivatives

Info

Publication number
IL128535A
IL128535A IL12853597A IL12853597A IL128535A IL 128535 A IL128535 A IL 128535A IL 12853597 A IL12853597 A IL 12853597A IL 12853597 A IL12853597 A IL 12853597A IL 128535 A IL128535 A IL 128535A
Authority
IL
Israel
Prior art keywords
alpha
derivatives
dien
triol
acyloxy
Prior art date
Application number
IL12853597A
Other languages
English (en)
Other versions
IL128535A0 (en
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7804358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL128535(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IL128535A0 publication Critical patent/IL128535A0/xx
Publication of IL128535A publication Critical patent/IL128535A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12853597A 1996-09-03 1997-08-29 Process for r-epimer enrichment of 16, 17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11 beta, 16 alpha, 17 alpha-triol-3,20-dione derivatives IL128535A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635498A DE19635498A1 (de) 1996-09-03 1996-09-03 Verfahren zur Epimerenanreicherung
PCT/EP1997/004716 WO1998009982A1 (fr) 1996-09-03 1997-08-29 Procede d'enrichissement en r-epimeres de derives 16,17-acetal de derives de 21-acyloxy pregan-1,4-dien-11-beta.,16.alpha.,17.alpha.-triol-3,20 dione

Publications (2)

Publication Number Publication Date
IL128535A0 IL128535A0 (en) 2000-01-31
IL128535A true IL128535A (en) 2003-07-06

Family

ID=7804358

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12853597A IL128535A (en) 1996-09-03 1997-08-29 Process for r-epimer enrichment of 16, 17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11 beta, 16 alpha, 17 alpha-triol-3,20-dione derivatives

Country Status (18)

Country Link
US (1) US6787533B1 (fr)
EP (1) EP0929566B1 (fr)
JP (1) JP3807509B2 (fr)
AT (1) ATE229539T1 (fr)
AU (1) AU736840B2 (fr)
CA (1) CA2264863C (fr)
CL (1) CL2004001297A1 (fr)
CY (2) CY2454B1 (fr)
CZ (1) CZ298789B6 (fr)
DE (2) DE19635498A1 (fr)
DK (1) DK0929566T3 (fr)
EE (1) EE03927B1 (fr)
ES (1) ES2188984T3 (fr)
HU (1) HU228766B1 (fr)
IL (1) IL128535A (fr)
PL (1) PL186063B1 (fr)
PT (1) PT929566E (fr)
WO (1) WO1998009982A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
CA2430196C (fr) 2000-11-10 2010-01-26 Altana Pharma Ag Procede de production du 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxy-pregna-1,4-diene-3,20-dioe ou son 21-isobutyrate par transcetalisation
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
WO2004033478A2 (fr) 2002-10-08 2004-04-22 Sepracor Inc. Formes modifiees par l'acide gras des glucocorticoides
JP4755495B2 (ja) 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
EP1869064A2 (fr) * 2005-11-02 2007-12-26 Sicor, Inc. Procede perfectionne destine a la preparation de ciclesonide
WO2007092574A2 (fr) * 2006-02-08 2007-08-16 Sicor, Inc. Formes cristallines de ciclesonide
WO2008015696A2 (fr) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Procédé pour préparer le ciclésonide
WO2008062450A2 (fr) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Polymorphes cristallins de ciclésonide
JP2010503722A (ja) * 2006-09-19 2010-02-04 シプラ・リミテッド シクレソニドとその結晶変異体の調製方法
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
WO2009112557A2 (fr) * 2008-03-13 2009-09-17 Farmabios S.P.A. Procédé pour la préparation de dérivés de prégnane
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
KR20220119529A (ko) 2016-06-02 2022-08-29 애브비 인코포레이티드 글루코코르티코이드 수용체 작용제 및 이의 면역접합체
ES2877659T3 (es) 2017-12-01 2021-11-17 Abbvie Inc Agonista del receptor de glucocorticoides y sus inmunoconjugados
CN109293730A (zh) * 2018-10-23 2019-02-01 山东泰华生物科技股份有限公司 一种环索奈德的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378110B (fr) * 1972-05-19 1975-08-18 Bofors Ab
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5482935A (en) 1993-01-05 1996-01-09 American Home Product Corporation Anti-atherosclerotic use of 17 alpha-dihydroequilin
US5733901A (en) 1993-04-02 1998-03-31 Byk Gulden Lomberg Chemische Fabrik Gmbh Prednisolone derivatives
AU697541B2 (en) 1994-03-09 1998-10-08 Takeda Gmbh Novel silyl compounds and their use

Also Published As

Publication number Publication date
CL2004001297A1 (es) 2005-04-15
DE69717836D1 (de) 2003-01-23
AU736840B2 (en) 2001-08-02
ES2188984T3 (es) 2003-07-01
EP0929566A1 (fr) 1999-07-21
HU228766B1 (hu) 2013-05-28
CZ72799A3 (cs) 1999-09-15
HUP9904127A3 (en) 2001-02-28
CY2009010I1 (el) 2010-07-28
PT929566E (pt) 2003-04-30
US6787533B1 (en) 2004-09-07
HUP9904127A2 (hu) 2000-04-28
DE19635498A1 (de) 1998-03-26
PL186063B1 (pl) 2003-09-30
CY2009010I2 (el) 2010-07-28
CY2454B1 (en) 2005-06-03
EP0929566B1 (fr) 2002-12-11
PL331699A1 (en) 1999-08-02
CZ298789B6 (cs) 2008-01-30
EE9900079A (et) 1999-10-15
EE03927B1 (et) 2002-12-16
JP3807509B2 (ja) 2006-08-09
DK0929566T3 (da) 2003-04-07
IL128535A0 (en) 2000-01-31
WO1998009982A1 (fr) 1998-03-12
CA2264863C (fr) 2007-07-31
AU4456797A (en) 1998-03-26
DE69717836T2 (de) 2003-09-18
ATE229539T1 (de) 2002-12-15
CA2264863A1 (fr) 1998-03-12
JP2000517330A (ja) 2000-12-26

Similar Documents

Publication Publication Date Title
IL128535A (en) Process for r-epimer enrichment of 16, 17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11 beta, 16 alpha, 17 alpha-triol-3,20-dione derivatives
AU649472B2 (en) New pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions and method for the treatment of inflammatory conditions
ES8705462A1 (es) Un procedimiento para la preparacion de 16,17-acetales de derivados de pregnano
NZ333697A (en) Production of Drospirenone (6beta,7beta,15beta,16beta-dimethylene-3-oxo-17alpha-preg-4-en-21,17-carbolactone, DRSP), and an androstane-triol (ZK 92836) and an androstane-carbolactone (90965) as intermediates
HUT61570A (en) Process for producing pregna-1,4-diene-3,20-dione derivatives
SI0929566T1 (en) Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives
IL74642A0 (en) Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient
EP0276393A3 (en) Process for the preparation of 6-alpha, 9-alpha-difluoro-11-beta-17-alpha-dihydroxy-16-alpha-methyl-pregn-4-ene-3,20-dione and its derivatives
LV5274A3 (lv) 22(R,S)-11 beta,21-dihidroksi-16 alpha,17-butilidenbisoksipregna-1,4-dien-3,20-diona iegusanas panemiens
HU9503063D0 (en) New 16-(substituted methyl)-pregna-1,4-diene-3,20-dione derivatives and process for producing them
AR243198A1 (es) Procedimiento para la elaboracion de compuesto 9alfa-21-dihalogeno-11beta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metilp regna-1,4-dien-3,20-diona
ES8302458A1 (es) Procedimiento para preparar nuevas 1-substituido-6-n-propil-8-metilimidazo (1,5-d)-as-triazin-4(3h)-onas.
AR243199A1 (es) Procedimiento para elaborar compuestos de 9alfa,21-dihalogeno-llbeta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metil- pregna-1,4-dien-3,20- diona
ZA919813B (en) Use of 2beta,16beta-diamino-3alpha,17-dihydroxy androstane derivatives
RO89499A2 (fr) Procede de purification de l'acetate de 17,21-dihydro0ypregna-1,4-dien-3,11,20-trione
HU9902345D0 (en) New pregna-1,4-diene-3,20-dione-derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired